📰 Epic Sciences Inc News
Page 2 - Epic Sciences Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Epic Sciences Inc. Real-time updates on events, politics, business and more.
August 19, 2022
The global cancer stem cells market expected to grow by 2026 due to rising prevalence of cancer. The breast cancer sub-segment is expected to be highly profitable. Market in the North America
June 2, 2022
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
June 2, 2022
/PRNewswire/ -- Epic Sciences, Inc. ("Epic" or "Epic Sciences"), a privately held diagnostics company, has completed a $43 million first close of its Series F...
June 1, 2022
/PRNewswire/ -- Epic Sciences, Inc. ("Epic" or "Epic Sciences"), a privately held diagnostics company, has completed a $43 million first close of its Series F...
May 9, 2022
/PRNewswire/ -- The Breast Cancer Liquid Biopsy Market size is expected to grow by USD 464.12 million from 2021 to 2026, at a CAGR of 16.35% during the...
May 4, 2022
/PRNewswire/ -- Epic Sciences, Inc. has added DefineMBC™, a novel comprehensive blood-based test for characterizing metastatic breast cancer, to its CLIA...
April 14, 2022
Business Scoop provides news and views on Business and Markets from New Zealand
February 24, 2022
/PRNewswire/ -- Epic Sciences, Inc. today announced it has partnered with Fulgent Genetics (NASDAQ:FLGT) to deliver DefineMBC comprehensive profiling results...
January 27, 2022
/PRNewswire/ -- Biosplice Therapeutics, Inc., a clinical-stage biotechnology company pioneering therapeutics based on CLK/DYRK kinase modulation for major...
January 27, 2022
/PRNewswire/ -- Biosplice Therapeutics, Inc., a clinical-stage biotechnology company pioneering therapeutics based on CLK/DYRK kinase modulation for major...